The discrepancy in the findings of the relationship between the circulating MMP-9/BDNF and clinical outcome may partly be due to most studies with a single-occasion measurement of the prognostic metrics, which prevents studying the longitudinal changes of MMP-9 and BDNF during the acute stage of ischemic stroke. This evidence concerns the gene MMP9 and ischemic stroke.